Pharmacy Quality Scheme

Document first published:
Page updated:
Topic:
Publication type:

The Pharmacy Quality Scheme (PQS) forms part of the Community Pharmacy Contractual Framework (CPCF). It supports delivery of the NHS Long Term Plan and rewards community pharmacy contractors that deliver quality criteria in three quality dimensions: clinical effectiveness, patient safety and patient experience.

Summary

This document replaces guidance issued for all previous schemes and provides further detail for contractors regarding how they demonstrate compliance with the scheme requirements.

PDF version. Updated June 2023.

Link

Summary

Accessible web page version. Updated June 2023.

Link

Summary

Report of the audit of non-steroidal anti-inflammatory drugs (NSAIDs) as part of the Quality Payment Scheme for 2018/19.

Summary

Quality improvement report on the BMJ website.

Summary

This report details the results and findings of the 2019/20 high risk medicines audit report for lithium, methotrexate, amiodarone and phenobarbital and makes recommendations on further actions.

Link

Summary

This report details the results and findings of the valproate audit and makes recommendations on further actions to reduce preventable harm.

Link

Summary

This audit was conducted as part of the 2021/2022 pharmacy quality scheme (PQS). 9,303 pharmacies participated in this audit and submitted data for 131,526 patients over a 7-month period between 1 September 2021 to 31 March 2022.

Summary

This paper reviews the use of the TARGET antibiotic checklist incentivised in the Pharmacy Quality Scheme 2021 to 2022.

Summary

This paper reviews all antimicrobial stewardship activities incentivised in the Pharmacy Quality Scheme from 2020 to 2022.

Summary

Published 30 May 2023.

Link

Summary

Full details of the UTI results.

Summary

Key findings and recommendations of the Pharmacy Quality Scheme’s (PQS) AMS requirements for 2022/23. Published 31 August 2023.